Blog
RSS FeedPosted by Michael Wonder on 13 Jan 2021
Swissmedic authorises COVID-19 Vaccine Moderna for use in Switzerland
12 January 2021 - Swiss Federal Government has secured 7.5 million doses and first deliveries expected to begin in January. ...
Posted by Michael Wonder on 06 Jan 2021
MorphoSys and Incyte announce the acceptance of the Swissmedic marketing authorisation application for tafasitamab
5 January 2021 - The Swissmedic marketing authorisation application seeks approval for tafasitamab in combination with lenalidomide for the treatment ...
Posted by Michael Wonder on 21 Dec 2020
Swissmedic approves Buvidal for the treatment of opioid dependence
18 December 2020 - Camurus announced today that the Swiss agency for therapeutic products, Swissmedic, has approved weekly and monthly Buvidal ...
Posted by Michael Wonder on 20 Dec 2020
Swiss to start Pfizer COVID-19 vaccine jabs after watchdog's OK
19 December 2020 - Switzerland will start getting doses of COVID-19 vaccine from Pfizer and partner BioNTech within days after ...
Posted by Michael Wonder on 10 Dec 2020
Switzerland ramps up COVID-19 vaccine order
9 December 2020 - Switzerland has increased its coronavirus vaccine order with Moderna by three million doses. ...
Posted by Michael Wonder on 09 Dec 2020
Switzerland secures three million doses of Pfizer/BioNTech vaccine
7 December 2020 - Switzerland has signed an agreement with a third manufacturer of COVID-19 vaccines for three million doses. ...
Posted by Michael Wonder on 03 Dec 2020
Incomplete data stalls Swiss authorisation of COVID-19 vaccines
3 December 2020 - Switzerland’s medical regulator Swissmedic says it lacks the necessary information to sign off on three different coronavirus ...
Posted by Michael Wonder on 16 Nov 2020
Swissmedic begins rolling review of Moderna’s mRNA vaccine against COVID-19 (mRNA-1273)
13 November 2020 - Moderna completed enrolment of its Phase 3 COVE study of mRNA-1273 on October 22. ...
Posted by Michael Wonder on 20 Oct 2020
Swissmedic fast-tracks second anti-viral vaccine
19 October 2020 - Swissmedic said the United States pharmaceutical company Pfizer submitted an application for the authorisation of a ...
Posted by Michael Wonder on 07 Oct 2020
Swissmedic reviewing AstraZeneca’s COVID-19 vaccine
6 October 2020 - Swiss drug authority Swissmedic has begun evaluating the so-called “Covid-19 Vaccine AstraZeneca”. ...
Posted by Michael Wonder on 22 Aug 2020
Swissmedic approval times slow down
20 August 2020 - Swissmedic took 4% longer to process each new application for a new active substance (NA NAS) ...
Posted by Michael Wonder on 20 Aug 2020
Swiss data protection chief pushes back on drug pricing secrecy
20 August 2020 - A proposed change to the new health insurance law that seeks to keep drug prices under lock ...
Posted by Michael Wonder on 13 Aug 2020
Drug prices fall in Switzerland but generics remain expensive
13 August 2020 - Switzerland is narrowing the gap with other European countries when it comes to the cost of medicines. ...
Posted by Michael Wonder on 21 Jul 2020
PharmaMar has filed lurbinectedin for Temporary Marketing Authorisation with the Swiss Agency for Therapeutic Products
20 July 2020 - The filing is based on the Phase II multi-centre basket trial efficacy data. ...
Posted by Michael Wonder on 05 Jul 2020
Switzerland fast-tracks anti-viral medication against COVID-19
2 July 2020 - Swissmedic, the agency that oversees the use of medicaments in Switzerland, took days to fast-track approval ...